This is a study of safety and tolerability of a drug called SLS-005 in adults, aged 18 to 75 years with selected neurodegenerative diseases [up to 4 patients wi
Study testing SLS-005 to assess its safety and tolerability in people with Huntington's disease.
Not yet recruitingNot specifiedDrugANZCTRTreatment trial
Recruiting in: Australia
Sponsor: Avance Clinical
Preparing a short plain-English summary.